NZ518919A - Production of peptides by fedbatch cultivation of a microorganism - Google Patents

Production of peptides by fedbatch cultivation of a microorganism

Info

Publication number
NZ518919A
NZ518919A NZ518919A NZ51891900A NZ518919A NZ 518919 A NZ518919 A NZ 518919A NZ 518919 A NZ518919 A NZ 518919A NZ 51891900 A NZ51891900 A NZ 51891900A NZ 518919 A NZ518919 A NZ 518919A
Authority
NZ
New Zealand
Prior art keywords
oscillation
cultivation
organic carbon
carbon source
feed
Prior art date
Application number
NZ518919A
Inventor
Andreas Castan
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NZ518919A publication Critical patent/NZ518919A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • C07K14/615Extraction from natural sources

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. The cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed, without exhaustion of the organic carbon source during the oscillation period, wherein the oscillation has a wave period of from about 1 to about 30 minutes. The microorganism is a biological host selected from the group consisting of bacteria, yeast and animal cell. The cultivation conditions remain aerobic.

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">WO 01/42420 <br><br> #*CT/SEO0/O2373 <br><br> 518919 <br><br> Production of peptides by fedbatch cultivation of a microorganism.' <br><br> The invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. The cultivation is carried out by the addition of the organic carbon source by oscillation feed and/or by oscillation variation of stkring speed, e.g. in a square or sinus wave pattern. Preferably the organic carbon source is glucose and the recombinant peptide is growth hormone. <br><br> BACKGROUND <br><br> Recombinant human proteins have become important pharmaceuticals. The combination of recombinant DNA technology and large-scale processes has enabled production of proteins that might otherwise have been impossible or too expensive to obtain from natural sources. For instance human growth hormone (hGH), immune interferon, tissue plasminogen activator (tPA) and human insulin are now commercial available by recombinant DNA technology. <br><br> However, the organism in large-scale bioprocesses is exposed to a changing environment and also respond to this. Differences in the production of recombinant proteins have been observed when increasing the reactor size. E.g. Riesenberg D et al. in Appl Microbiol Biotechnol 34:77-82, 1990, showed that the amount of human interferon alpha 1 was reduced by a factor of two when the culture volume was increased from 15 to 250 L. <br><br> When scaling up bioprocesses, differences in the micro-environment, such as concentration, and gradients, are likely to be expected. <br><br> WO 01/42420 <br><br> PCT/SE00/02373 <br><br> Concentration gradients of substrates, such as the carbon source added at limiting feed (fed-batch), ammonia for pH titration and oxygen, are to be expected as the result of changing geometry and process parameters as well as the choice of feed position. Most organisms 5 respond to rapid environmental changes and can also change their metabolism in a time-scale of seconds or less. <br><br> Pulse addition of glucose and the oscillating glucose concentration within the fennentor have earlier been studied with regard to yield and expression. <br><br> Pulse addition of glucose, i.e. addition of glucose within a few seconds when the culture 10 had reached the steady state, was shown to induce gapA gene expression strongly and very rapidly (Gschaedler, Anne; et al, Biotechnol. Bioeng. (1999), 63(6), 712-720). <br><br> The effect of oscillating glucose concentration within the fennentor on biomass yield and acetate formation has been studied. The conclusion was, that the lower biomass yield and the higher acetate formation were caused by the cell response to the glucose oscillation 15 within the fennentor when comparing large and small scale cultivations. (Bylund, F et al, Bioprocess Eng. (1999), 20(5), 377-389). <br><br> Pulse addition of the growth substrate (glucose) at appropriate time intervals allowing for significant starvation period between two consecutive pulses during fed-batch cultivation have positive effects on stabilizing plasmid and enhancing protein production. (Cheng, 20 Chinyuan et al-Biotechnol. Bioeng. (1997), 56(1), 23-31). The pulse addition was repeated for 4-5 times at about 6 hours intervals. The result shows that the periodic glucose starvation feeding strategy can maintain a stable plasmid-carrying cell fraction and a stable specific productivity of the recombinant protein. On the contrary, without glucose starvation, the fraction of plasmid-carrying cells and the specific productivity continue to 25 drop during the fed-batch cultivation, which would greatly reduce the product yield and limit the duration that the cultivation can be effectively operated. <br><br> WO 01/42420 PCT/SE00/02373 <br><br> 3 <br><br> Wang, Zhengjun et al. Biotechnol. Bioeng. (1993), 42(1), 95-102 have shown that a glucose pulse at the end of batch culture in YPD (rich complex medium) facilitated the transport of residual cytoplasmic invertase. <br><br> US 5912133 discloses a fed-batch cultivation, wherein the carbon source concentration is at 5 a constant low level under 5g/L and wherein the carbon source is added in at least two feedings. The carbon source should be exhausted after the first feeding and before the second feeding. <br><br> It is also known to use external magnetic field with periodic variations and product stirring movement in a cell culture vessel. (DD271850). Thereby introduced material is effectively 10 distributed with no local and potentially damaging concentrations <br><br> None of the reports disclose a repeated oscillation of organic carbon source in a square or sinus wave pattern, which can be characterized by amplitude and frequency. On the contrary it can be concluded from prior art that there should be a significant starvation 15 period between two consecutive feedings (Cheng et al.) or that that a glucose pulse should only be done at the end of batch culture (Wang et al.). <br><br> The most applied technique to achieve high cell densities is the glucose-limited fed-batch. In a fed-batch process, all media components are supplied in excess as in a batch process, 20 except for example the carbon source. A feed with a substrate solution, often glucose, is fed to the bioieactor with a rate that ensures that this substrate component is growth limiting. This substrate limitation allows control of the growth rate and the sugar uptake. By limiting the sugar uptake and thereby the reaction rate, engineering limitations, such as excessive heat evolution and oxygen limitation can be avoided. Glucose uptake can be divided in 25 three reactions, glucose that is used for anabolism, glucose consumption for maintenance, which is the housekeeping requirement of the cell and glucose consumption to fuel growth. The yield in the last two reactions is approximately 1.07 gQ2 g"^^. Control of the growth rate can therefore be used to control the oxygen consumption and heat generation associated <br><br> WO 01/42420 <br><br> PCT/SE00/02373 <br><br> 4 <br><br> (followed by page 4a) <br><br> with growth. Furthermore, substrate limitation peimits metabolic control by which overflow metabolism (i.e. acetate formation in case of E coli) and catabolite repression can be avoided. In the baker's yeast process sugar limitation is used throughout the process to avoid over-flow metabolism that results in excessive ethanol production (George et al. (1998). Bioprocess Eng 18: 135-142.). Inhibitory acetate production by E coli is avoided in the same way (See e.g. Lee, S. Y. (1996). Trends Biotechnol 14: 98-105). <br><br> In the production of recombinant proteins the oxygen transfer and the dissolved oxygen tension is particularly important for the yield and quality of the product (See e.g. Bhattacharya and Dubey (1997) Enzyme Microb Technol 20: 355-360).A fed-batch process is therefore often the first choice when designing high-cell-density processes in E. coli. <br><br> SUMMARY OF THE INVENTION <br><br> The invention describes a method to increase the production of recombinant peptides with improved rhGH quality and yield. This process is performed in a fed-batch bioreactor with a carbon source that is featured by oscillation in the feed and/or by oscillation variation of stirring speed. <br><br> Accordingly, one aspect of the present invention provides a method for the production of recombinant peptides by fed-batch cultivation of a micro-organism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts, wherein the cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed, without exhaustion of the organic carbon source during the oscillation period, wherein the oscillation has a wave period of from about 1 to about 30 minutes, wherein the microorganism is a biological host selected from the group consisting of bacteria, yeast and animal cell, and wherein the cultivation conditions remain aerobic. <br><br> FIGURES <br><br> Figure 1 shows mode of operation Figure 2 shows % amount of rfaGH calculated on standard. <br><br> Figure 3 shows % of ihGH variants. <br><br> 4a <br><br> (followed by page 5) <br><br> THE INVENTION <br><br> We have to our great surprise found that when the glucose feed was varied in oscillation feed and/or the stirring speed was performed in oscillation variation in a fed-batch cultivation, improved rhGH quality and yield i.e. less amount of not wanted products, was obtained. The word oscillation used here can also be described as pulses or by up and down-shifts. <br><br> The invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. This includes also a complex cultivation media. <br><br> WO 01/42420 <br><br> PCT/SE0O/O2373 <br><br> By the expression cultivation of a microorganism is meant cultivation of a biological host such as bacteria, yeast or animal cell. <br><br> The cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed. Hie oscillation feed and/or the oscillation 5 variation of stirring speed can be performed during the entire cultivation process or during the production phase after the induction of the recombinant protein. The oscillation feed can have a square wave or sinus wave pattern. No starvation should occur during the oscillation period. The glucose added is consumed by the cells, but not until total starvation. The carbon source should never be exhausted during the process and there is no need for 10 measuring its concentration during cultivation. The density of the cells should be high preferably above 10 g/L and more preferably above 20 g/L and even more preferably above SO g/L during cultivation. However, aerobic conditions should be maintained. <br><br> The biomass concentration in the experiments was in of the order of 40 g/L. <br><br> Preferably the organic carbon source is glucose and the recombinant peptide is preferably IS growth hormone. <br><br> The period time for the oscillation curve can easily be determined for each protein, type of cultivation, medium etc by a person skilled in the art. The period for the oscillation time can be e.g. a short time of one minute as exemplified here, but periods of five, 10 , 30 minutes or longer periods are also within the scope of the invention. <br><br> 20 The amplitude can be varied from about ± 5 % up to ± 100 %, e.g. ± 20, ± 30, ± 40, ± 50 or ± 60%, which also easily is to be determined by a person skilled in the art. <br><br> Oscillation periods can be interrupted by periods of constant glucose addition or constant stirring speed. <br><br> The addition of glucose is here illustrated as a square wave function. The sinus wave 25 function is especially suitable for the stirring speed. Also variation between sinus and square can be used. <br><br> According to our invention, the concentration of the carbon source and oxygen changes proportionally with the oscillation of the feed and agitation, respectively. <br><br> WO 01/42420 <br><br> PCT/SE00/02373 <br><br> 6 <br><br> The influence of substrate feed on the quality of a recombinant protein produced by Escherichia coli has specifically been studied in the production of recombinant human growth hormone (rhGH)in an aerobic fed-batch process as a model system. <br><br> Our invention and the findings are further confirmed in Bylund, Castan, Mikkola, Veide 5 and Larsson; Biotechnology and Bioengineering 69 (2), 119-128 (2000). <br><br> MATERIAL AND METHODS Organism and Medium <br><br> Escherichia coli (W3110) with a pBR derived plasmid coding for recombinant human 10 growth hormone (rhGH) and antibiotic resistance was used in the performed cultivations. This rhGH form is a 22 kDa protein consisting of 191 amino acids with two intramolecular disulphide bridges. The protein is secreted to the periplasm where the disulphide bridges are formed. <br><br> Cultivations were performed in a glucose mineral salt medium. The media used, with some 15 minor modifications, is described by Forsberg G et al. in J. Biol. Chem. 272 (1997) 12430-1243S <br><br> Media components together with distilled water were sterilised in the bioreactor at 121 °C. After sterilisation, sterilised magnesium sulphate, trace elements and antibiotics were added separately. Breox was added when needed for foam control. The feed solution had a 20 glucose concentration of 590 g/1. <br><br> Cultivation Procedure and Bioreactors <br><br> Exponentially growing cells from the seed fennentor were transferred to the production bioreactor. The inoculum volume was about 10 % of final total volume. After the transfer 25 procedure the glucose feed was immediately started. The feed profile consisted of three different phases: firstly, there was an exponential feed phase; secondly, the feed was turned to constant rate when the estimated maximum oxygen transfer capacity of the bioreactor <br><br> WO 01/42420 <br><br> PCT/SE00/02373 <br><br> 7 <br><br> was approached and finally the feed rate was decreased to 80 % of its maximum value at the time for induction. <br><br> The addition of glucose was made as a square wave function that was superimposed to the standard feed as illustrated in Figure 1. <br><br> 5 <br><br> Temperature and pH were controlled near the optimal value for E.coli growth. All cultivations were performed in a 15 I CF 3000 Chemap-Fennenter (Switzerland) stirred tank reactor (STR) with a start volume of 7 1. The volume increased during the feed phase up to 9 1. <br><br> 10 <br><br> Analytical Procedures. <br><br> Samples for product analyses were achieved from the extraction of the pellet fraction of 5 ml centrifuged cell suspension. This extraction method releases the periplasmic fraction of proteins. Centrifugation was perfonned at 5000 rpm for 15 min at +4°C. Extraction buffer 15 consisted of (per litre): Tris-HCl, 0.9837 g; Tris-base, 0.4551 g; EDTAx2H20, 0.372 g. Purity and quantity of rhGH were determined by hydrophobic interaction chromatography (HIC). HIC was perfonned on a TSK phenyl 5PW column, Tosoh Haas. Four different variants of rhGH are separated by a decreasing salt gradient and detected with UV at 230 nm: (des-Phel)-rhGH (LMW), rhGH, (trisulfide Cysl82-Cysl89)-rhGH and clipped 20 142/143-rhGH (clipped variant). <br><br> RESULTS <br><br> The result is shown in Figures 2 and 3. <br><br> In the Figures 1-3, rhGH is produced 25(a) by a standard method <br><br> (b) by a glucose feed that follow a square, wave with an amplitude of ± 30% of the standard value and a frequency of 1 minute and <br><br> WO 01/42420 <br><br> PCT/SEO0/02373 <br><br> 8 <br><br> (c) by a standard glucose feed but an stirring profile (at a rate of 800 - 1200 rpm) that follow a square wave with an amplitude of ± 20% and a frequency of 1 minute. <br><br> Figure 2 shows the amount of rhGH when rhGH is prepared by the different methods. 5 It is clear from the experiment that the amount of rhGH was much higher when glucose was added in an oscillation feed and by oscillation variation of stirring speed. <br><br> Figure 3 shows the amount in % of total of rhGH 22kDa, i.e. the proper form of rhGH (black) and the amount of clipped variants (white) when the methods (a), (b) and (c) are 10 used. It can be seen that the yield of the proper form of rhGH, i.e. 22 kDa is higher when glucose was added in an oscillation feed and by oscillation variation of stirring speed. <br><br> CONCLUSIONS <br><br> Optimisation of the glucose feeding strategy or stirring profile by using oscillation in square 15 or sinus , wave pattern gives the advantages that the yield of the protein is higher, that proteolysis could be avoided at a higher level and that the purification thereby is easier than when the organic source is fed without oscillation feed. <br><br></p> </div>

Claims (9)

<div class="application article clearfix printTableText" id="claims"> <p lang="en"> WHAT WE CLAIM IS:<br><br>
1. Method for the production of recombinant peptides by fed-batch cultivation of a micro-organism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts, wherein the cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed, without exhaustion of the organic carbon source during the oscillation period, wherein the oscillation has a wave period of from about 1 to about 30 minutes, wherein the microorganism is a biological host selected from the group consisting of bacteria,<br><br> yeast and animal cell, and wherein the cultivation conditions remain aerobic.<br><br>
2. Method according to, claim 1 in which the organic carbon is glucose.<br><br>
3. Method according to claim 1 or 2 in which the microorganism is E Coli.<br><br>
4. Method according to any of claims 1 to 3 in which the oscillation feed has a square wave pattern.<br><br>
5. Method according to any of claims 1 to 3 in which the oscillation feed has sinus wave i-<br><br> patterns.<br><br>
6. Method according any of claims 1 to 5 in which the recombinant peptide is growth hormone.<br><br>
7. Method according any of claims 1 to 6 in which the recombinant peptide is human growth hormone.<br><br>
8. A method according to claim 1 substantially as herein described with reference to any example thereof and with or without reference to the accompanying drawings.<br><br>
9. A recombinant peptide produced by a method according to any one of claims 1 to 8.<br><br> ' intellectual property OTOCF OF N2<br><br> 1 1 AUG 2003<br><br> RECEIVED<br><br> </p> </div>
NZ518919A 1999-12-09 2000-11-29 Production of peptides by fedbatch cultivation of a microorganism NZ518919A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904502A SE9904502D0 (en) 1999-12-09 1999-12-09 Production of peptides
PCT/SE2000/002373 WO2001042420A1 (en) 1999-12-09 2000-11-29 Production of peptides by fedbatch cultivation of a microorganism

Publications (1)

Publication Number Publication Date
NZ518919A true NZ518919A (en) 2003-10-31

Family

ID=20418057

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ518919A NZ518919A (en) 1999-12-09 2000-11-29 Production of peptides by fedbatch cultivation of a microorganism

Country Status (11)

Country Link
EP (1) EP1244769A1 (en)
JP (1) JP2003516140A (en)
KR (1) KR20020060258A (en)
CN (1) CN1267562C (en)
AU (1) AU780122B2 (en)
CA (1) CA2392268A1 (en)
HK (1) HK1053326A1 (en)
IL (1) IL149624A0 (en)
NZ (1) NZ518919A (en)
SE (1) SE9904502D0 (en)
WO (1) WO2001042420A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337041T3 (en) * 2002-09-20 2010-04-20 Pharmacia Corporation PROCEDURE TO DECREASE THE AGGREGATION LEVELS OF PEGILATED PROTEIN.
TWI281864B (en) * 2002-11-20 2007-06-01 Pharmacia Corp N-terminally monopegylated human growth hormone conjugates and process for their preparation
EP1828375B1 (en) * 2004-12-21 2008-05-07 USV Limited Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms
WO2008010005A1 (en) * 2006-07-14 2008-01-24 Abb Research Ltd A method for on-line optimization of a fed-batch fermentation unit to maximize the product yield.
JP5924343B2 (en) * 2010-09-21 2016-05-25 フェリング ベスローテン フェンノートシャップ Improved method of recombinant human growth hormone production
CN106222309A (en) * 2016-07-28 2016-12-14 山东金朗生物科技有限公司 A kind of fermentable produces the control of additive raw material method improving L alanine yield
CN108624516B (en) * 2017-03-20 2022-08-26 华东理工大学 Method for improving metabolite amount in fermentation cells and preparing IDMS standard substance
GB202010934D0 (en) * 2020-07-15 2020-08-26 Ipsen Biopharm Ltd Controlling operation of a bioreactor vessel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD271850A1 (en) * 1988-05-12 1989-09-20 Adw Ddr MIXING DEVICE FOR FLUID DISTRIBUTION AND / OR FOR GAS ADMISSION IN BIOLOGICAL CULTURAL SUSPENSIONS WITH PENDULUM ROTORS
BE1008008A3 (en) * 1990-11-30 1995-12-12 Ajinomoto Kk Method and apparatus for adjusting the concentration of carbon source in aerobic culture microorganism.

Also Published As

Publication number Publication date
KR20020060258A (en) 2002-07-16
CN1267562C (en) 2006-08-02
AU1910501A (en) 2001-06-18
CN1409755A (en) 2003-04-09
HK1053326A1 (en) 2003-10-17
WO2001042420A1 (en) 2001-06-14
SE9904502D0 (en) 1999-12-09
CA2392268A1 (en) 2001-06-14
EP1244769A1 (en) 2002-10-02
JP2003516140A (en) 2003-05-13
AU780122B2 (en) 2005-03-03
IL149624A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
US6680181B2 (en) Production of peptides
Wong et al. Effect of post‐induction nutrient feeding strategies on the production of bioadhesive protein in Escherichia coli
JP5587795B2 (en) Fermentation medium and process thereof
Tripathi High yield production of heterologous proteins with Escherichia coli
Tabandeh et al. Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli
AU780122B2 (en) Production of peptides by fedbatch cultivation of a microorganism
Yim et al. High-level secretory production of human granulocyte-colony stimulating factor by fed-batch culture of recombinant Escherichia coli
US5955323A (en) Automated high-yield fermentation of plasmid DNA in Escherichia coli
US20110189733A1 (en) Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms
AU775301B2 (en) Method for increasing the yield of recombinant proteins in microbial fermentation processes
CA2671076A1 (en) Method for controlling the growth of cell culture
ES2191064T5 (en) PROCEDURE TO PRODUCE PROTEINS.
Delacruz et al. Bioprocess development to improve foreign protein production from recombinant Streptomyces
Park et al. Fed-batch fermentations of recombinant Escherichia coli to produce Bacillus macerans CGTase
US20120258502A1 (en) Method of producing recombinant plasmid dna using substantially solid growth medium
US11866714B2 (en) Promoter for yeast
CN114891712B (en) Recombinant escherichia coli for improving yield of N-acetylneuraminic acid
UA76661C2 (en) A method for producing recombinant humanæs insulin
CN118373922A (en) Application of soluble tag protein in preparation of semaglutin main chain
US20060286631A1 (en) Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene
Öztürk Semi-defined medium based feeding strategy development for human growth hormone production by recombinant Bacillus subtilis
CN111560066A (en) Medical recombinant human collagen and preparation method thereof
Wei Process studies to produce a striped bass growth hormone fusion protein using a recombinant Escherichia coli system
Korz et al. Computer-Controlled High Cell Density Cultivation of Recombinant Escherichia coli Producing ß-Galactosidase
Wanchaitanawong Production of a recombinant protein in fed-batch culture of Escherichia coli strains

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)